António Félix da Costa grew up watching his two brothers race cars, and, ever since his oldest brother took him on a racetrack, he knew it was the choice for him.
"It drives me really," da Costa explained. "You know, it's the thing that makes me get out of bed in the morning. It's something I'm good at, probably the only thing that I'm very good at. And, you know, so I put all my energy, my time, my passion into it."
Da Costa races for DS Techeetah as one of its Formula E drivers, and was the Formula E 2019-2020 season champion. The all-electric car competition joined the FIA World Championship series in 2020, the same governing body that oversees Formula 1.
These cars go fast, up to 173 miles per hour, but they're also sending a sustainable message that the future can be electric.
"I'm not against having races with petrol cars and putting that as a show, but for us on the day-to-day, going from A to B on the streets, why do we need 700 horsepower, V12 cars, you know, polluting the world?" he said.
Formula E Grows
Formula E started in 2014 and has continued to grow. In its seventh season, it visited eight cities during its 15 rounds. Next season, it will expand to 16 races across 12 cities and four continents. The cars are mostly identical to each other, except for the proprietary technology in the back, including the powertrains and software, which have been improving.
"We're running with a lot more power than we did from season one," explained Michael Andretti, owner of Andretti Motorsports. "We're going over twice as far of a distance. So that's what's been pretty amazing."
The evolution has been remarkable, said DS Techeetah Formula E team lead Mark Preston.
"I think at the beginning, most people thought we really thought we were crazy," Preston said. "'You can't race an electric car' to now when we've got new powertrains and new jobs coming up in a couple of years that will take us another step in terms of performance."
Hotbed of Testing
What's more, the technology eventually transfers to the road.
"There's things that we're doing here that's going to end up on your road car," Andretti said. "It's no different than in other types of racing where the OEMs [original equipment manufacturers] use it as a testbed to develop new things, new technologies."
Porsche, for example, has committed to a CO2-neutral balance sheet by 2030, meaning most of its cars will be electric. Its Formula E cars will help develop that technology.
"Electric cars are part of sustainability and sustainability is really important to Porsche," said Porsche Formula E director factory motorsport Pascal Zurlinden. "We use [Formula E] as a label to develop the new technology for the future."
Rethinking Race Strategy
But driving an electric race car requires a different kind of strategy. Because the batteries recharge during the race, you have to learn how to conserve energy, said Porsche Formula E driver André Lotterer.
"We all have the same battery capacity and the same power output," he pointed out. "But if you drive flat out in a race, you won't make it to the end. So we need to save like 20 or 30 percent of the energy in coasting and in regenning."
Though it's a different kind of race, it's still fun. Plus it highlights an important cause, the environment.
"This is the first time in my career that we can do this, in such a strong way and do something for the planet, which is very meaningful," Lotterer said. "I think we all have the responsibility to do our share for that."
The FDA has granted emergency use authorization to Pfizer's pill to treat covid-19. The treatment, called Paxlovid, is the first antiviral covid-19 pill that people can take at home.
Pfizer says the pill can reduce the risk of severe illness by 90 percent and is intended for people at high risk for severe disease, including those over 65, people with obesity, diabetes, or a weakened immune system. Professor Peter Pitts, Founder, Center for Medicine in the Public Interest & Former FDA Associate joined Wake Up with Cheddar to discuss.
Ahead of a four day week for the markets due to the upcoming Christmas holiday, investors hoping for a quiet end to the year, or even a Santa Claus rally, may not be in luck. Investors are still digesting the latest from the Fed regarding a quicker than expected taper, as well as ever increasing blow back as the Omicron variant spreads. Octavio Marenzi, CEO of Opimas LLC, explains why the markets have been so volatile ever since the emergence of the latest variant and what to expect going forward into 2022.
Carlo and Baker cover the heartening news on the Covid front ahead of the holiday, plus President Biden punting student loan repayments again, a new space telescope and Love, Hate, Ate: Christmas Eve Eve Edition!
Pfizer, one of the makers of a currently available COVID-19 vaccine, has taken another critical step forward in combatting the pandemic by getting regulatory approval for Paxlovid, a pill treatment rather than IV or injection as others have been. Dr. Purvi Parikh, an immunologist with the Allergy and Asthma Network, spoke to Cheddar about the ramifications of the authorization. "This is huge, especially because we know early treatment does keep people out of the hospital, especially with this antiviral," Parikh said. "The fact that people can start a regimen at home so they don't have to leave and further expose others is a big breakthrough." She also explained how the drug is a combination of two antiviral medications that are not without its risks but should be safe over the short term.
This year's worldwide semiconductor shortage limited the supply of everything from new cars to smartphones; and now, many in the chip industry expect the shortage to continue deep into 2022, and maybe even 2023. Semiconductor senior research analyst for Robert W. Baird & Co., Tristan Gerra, joins Cheddar News' Closing Bell to discuss.
Direct health care company Nomi Health recently raised $110 million in a Series A round. Nomi Health lets public and private organizations directly purchase healthcare at reduced costs, and pay providers in real-time. It also delivers healthcare directly to under-served communities via its fleet of mobile care units, which the company says is the largest in the country. Nomi Health says its mission is to improve the health care experience for all Americans. Nomi Health CEO Mark Newman joined Cheddar News' Closing Bell to discuss.
The airline industry says it is contending with staff shortages that threaten to hamper operations amid the COVID resurgence, andDelta Airlines CEO Ed Bastian called on the CDC to revise its guidance for vaccinated workers who test positive from a 10-day quarantine to just five. Chuck Liberman, chief investment officer and managing partner at Advisors Capital Management LLC, joined Cheddar to talk about the current guidance on isolation and why he believes the omicron variant calls for more relaxed guidance given its reportedly mild symptoms.
The boys discuss President Biden's plans to send out free rapid tests as the testing supply chain starts to buckle ahead of the holidays. Also, why aren't Americans having more babies, and The Matrix returns.
NASA is launching its new generation of space telescopes just before Christmas. The James Webb Space Telescope, set to launch on December 24th, will succeed the Hubble space telescope as the world's most powerful complex space observatory. The project has been 30 years in the making and is one of the most highly anticipated space science missions of the 21st century. Klaus Pontoppidan, astronomer and JWST Project Scientist at the Space Telescope Science Institute joined Cheddar's Opening Bell to discuss.
With Omicron becoming the dominant COVID-19 variant in the U.S., President Joe Biden announced that he will make 500 million rapid tests available to Americans in January 2022. Cheddar News speaks with Dr. Shereef Elnahal, President and CEO of University Hospital why testing is key to combatting the spread of the virus.
